Koumakpayi IH - Search Results

1

Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-kappaB signalling pathway and prognostic significance in prostate cancer.

Koumakpayi IH, Le Page C, Mes-Masson AM, Saad F. Koumakpayi IH, et al. Br J Cancer. 2010 Mar 30;102(7):1163-73. doi: 10.1038/sj.bjc.6605571. Epub 2010 Mar 9. Br J Cancer. 2010. PMID: 20216540 Free PMC article.

2

Influence of pH on the Cytotoxic Activity of Inositol Hexakisphosphate (IP6) in Prostate Cancer.

Betton B, Gannon PO, Koumakpayi IH, Diallo JS, Mes-Masson AM, Saad F. Betton B, et al. Among authors: koumakpayi ih. Front Oncol. 2011 Oct 31;1:40. doi: 10.3389/fonc.2011.00040. eCollection 2011. Front Oncol. 2011. PMID: 22655245 Free PMC article.

3

ErbB2/Her-2 regulates the expression of Akt2 in prostate cancer cells.

Le Page C, Koumakpayi IH, Péant B, Delvoye N, Saad F, Mes-Masson AM. Le Page C, et al. Among authors: koumakpayi ih. Prostate. 2012 May 15;72(7):777-88. doi: 10.1002/pros.21483. Epub 2011 Sep 19. Prostate. 2012. PMID: 21932427

4

Macropinocytosis inhibitors and Arf6 regulate ErbB3 nuclear localization in prostate cancer cells.

Koumakpayi IH, Le Page C, Delvoye N, Saad F, Mes-Masson AM. Koumakpayi IH, et al. Mol Carcinog. 2011 Nov;50(11):901-12. doi: 10.1002/mc.20766. Epub 2011 Mar 22. Mol Carcinog. 2011. PMID: 21438025

5

Ebp1 expression in benign and malignant prostate.

Gannon PO, Koumakpayi IH, Le Page C, Karakiewicz PI, Mes-Masson AM, Saad F. Gannon PO, et al. Among authors: koumakpayi ih. Cancer Cell Int. 2008 Nov 24;8:18. doi: 10.1186/1475-2867-8-18. Cancer Cell Int. 2008. PMID: 19025630 Free PMC article.

6

Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis.

Diallo JS, Aldejmah A, Mouhim AF, Fahmy MA, Koumakpayi IH, Sircar K, Bégin LR, Mes-Masson AM, Saad F. Diallo JS, et al. Among authors: koumakpayi ih. BJU Int. 2008 May;101(10):1302-9. doi: 10.1111/j.1464-410X.2008.07514.x. Epub 2008 Feb 21. BJU Int. 2008. PMID: 18294307

7

NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model.

Diallo JS, Aldejmah A, Mouhim AF, Péant B, Fahmy MA, Koumakpayi IH, Sircar K, Bégin LR, Mes-Masson AM, Saad F. Diallo JS, et al. Among authors: koumakpayi ih. Clin Cancer Res. 2007 Dec 1;13(23):7044-52. doi: 10.1158/1078-0432.CCR-07-1224. Clin Cancer Res. 2007. PMID: 18056181

8

Expression and nuclear localization of ErbB3 in prostate cancer.

Koumakpayi IH, Diallo JS, Le Page C, Lessard L, Gleave M, Bégin LR, Mes-Masson AM, Saad F. Koumakpayi IH, et al. Clin Cancer Res. 2006 May 1;12(9):2730-7. doi: 10.1158/1078-0432.CCR-05-2242. Clin Cancer Res. 2006. PMID: 16675564

9

EGFR and Her-2 regulate the constitutive activation of NF-kappaB in PC-3 prostate cancer cells.

Le Page C, Koumakpayi IH, Lessard L, Mes-Masson AM, Saad F. Le Page C, et al. Among authors: koumakpayi ih. Prostate. 2005 Oct 1;65(2):130-40. doi: 10.1002/pros.20234. Prostate. 2005. PMID: 15880609

10

Independent role of phosphoinositol-3-kinase (PI3K) and casein kinase II (CK-2) in EGFR and Her-2-mediated constitutive NF-kappaB activation in prostate cancer cells.

Le Page C, Koumakpayi IH, Lessard L, Saad F, Mes-Masson AM. Le Page C, et al. Among authors: koumakpayi ih. Prostate. 2005 Dec 1;65(4):306-15. doi: 10.1002/pros.20291. Prostate. 2005. PMID: 16015604

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results